All News

Researchers addressed the gut-first hypothesis of Parkinson disease by identifying how mucosal damage impacts risk of development.

Timothy Aungst, PharmD, Founder of The Digital Apothecary, discussed advancements in digital health and what to be aware of regarding the future of technology.

Scott Biggs, Director of Supplier Services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.

Johnson & Johnson announced results from its phase 3 GRAVITI trial exploring guselkumab’s results in subcutaneous (SC) induction and maintenance therapy for treating Crohn’s disease.

A.J. Lipka, Business Development Lead of Network Growth at Outcomes, discussed the impact of pharmacy-sponsored programming.

The addition of a 10 mg oxycodone hydrochloride tablet improves dosing flexibility and precision.

Researchers analyzed the lack of prevention and treatment options for managing drug-induced liver injury.

With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.

The NCPA 2024 Annual Convention and Expo runs through October 29, 2024, in Columbus, Ohio.

Industry experts gathered to discuss pharmacy benefit managers, their current grasp on the drug supply chain, and how it all impacts independent pharmacies.

PBM reform legislation has progressed further in Congress than ever before.

A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.

The digest was released at the NCPA 2024 Annual Convention and Expo.

Making the store’s front end a priority can increase revenue opportunities and boost pharmacy profit.

In case you missed it, this week we had stories about the FDA approval of Pfizer's RSV vaccine, vaccines and COVID-19 hospitalization in children, race-based disparities in multimodal analgesia, and more.

The Drug Enforcement Administration gives controlled substance licenses, and can just as easily take them away.

The first of a 2-part presentation focused on vaccines for COVID-19, flu, RSV, and pneumococcal disease.

The FDA has approved just the second treatment for uncomplicated urinary tract infections (UTIs) in the last 2 decades.

The cost effectiveness of biosimilar denosumab for postmenopausal osteoporosis varies significantly based on factors like adherence, subsequent therapies, and treatment duration.

As the H5 bird flu outbreak gradually impacts human health in the US, health care experts weighed in on possibilities of a future vaccine.

A series of posters presented at AMCP Nexus 2024 highlighted the evolving landscape of women's health, focusing on the use of medications for preterm birth prevention and the adoption of telehealth for prenatal consultations.

A recent study found the percentage of type 1 diabetes patients who were prescribed either GLP-1s or SGLT2 inhibitors increased from 0.7% to 8.3% between 2010 and 2023.

The new recommendations suggest vaccination at age 50, rather than age 65.

Adding to the mail-order options within big chain pharmacy, Walmart is promising prescription delivery in as quickly as 30 minutes.

Researchers addressed the association between sleep patterns and digestive diseases, as well as patients’ genetic likeliness of developing future digestive complications.

A study found that children aged 6 months or younger who are not eligible for vaccination were at the highest risk for hospitalization due to SARS-CoV-2.

In a comprehensive literature review, researchers addressed the impact cardiac surgery has on gastrointestinal outcomes.

Abrysvo is the only RSV vaccine approved for use in this age group.